Assignee
PROBIODRUG AG
DE·38 granted patents·19 pending applications·829 citations·filing 2000–2020
Top patents by PatentIndex Score
57 records- 0197US7732162B2Inhibitors of glutaminyl cyclase for treating neurodegenerative diseasesPROBIODRUG AG·Filed 2007·Granted Jun 8, 2010·51 cites·19 claims
- 0297US6548481B1Effectors of dipeptidyl peptidase IVPROBIODRUG AG·Filed 2000·Granted Apr 15, 2003·249 cites·14 claims
- 0396US7371871B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2004·Granted May 13, 2008·90 cites·20 claims
- 0496US7304086B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2005·Granted Dec 4, 2007·64 cites·38 claims
- 0596US6500804B2Method for the improvement of islet signaling in diabetes mellitus and for its preventionPROBIODRUG AG·Filed 2001·Granted Dec 31, 2002·97 cites·11 claims
- 0694US7381537B2Use of inhibitors of glutaminyl cyclases for treatment and prevention of diseasePROBIODRUG AG·Filed 2004·Granted Jun 3, 2008·62 cites·27 claims
- 0794US7109347B2Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agentsPROBIODRUG AG·Filed 2005·Granted Sep 19, 2006·19 cites·5 claims
- 0894US6844316B2Inhibitors of dipeptidyl peptidase IPROBIODRUG AG·Filed 2002·Granted Jan 18, 2005·38 cites·16 claims
- 0991US7368576B2Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agentsPROBIODRUG AG·Filed 2006·Granted May 6, 2008·9 cites·10 claims
- 1089US7462599B2Use of effectors of glutaminyl and glutamate cyclasesPROBIODRUG AG·Filed 2004·Granted Dec 9, 2008·31 cites·14 claims
- 1189US7435420B2Dipeptidyl peptidase IV inhibitors for the treatment of anxietyPROBIODRUG AG·Filed 2006·Granted Oct 14, 2008·8 cites·16 claims
- 1286US6949515B2Effectors of dipeptidyl peptidase IV for topical usePROBIODRUG AG·Filed 2002·Granted Sep 27, 2005·22 cites·19 claims
- 1385US10603367B2Humanized antibodiesPROBIODRUG AG·Filed 2018·Granted Mar 31, 2020·2 cites·18 claims
- 1485US9650362B2InhibitorsPROBIODRUG AG·Filed 2015·Granted May 16, 2017·5 cites·17 claims
- 1585US7741354B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2007·Granted Jun 22, 2010·11 cites·23 claims
- 1685US7625939B2Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase IV inhibitorsPROBIODRUG AG·Filed 2008·Granted Dec 1, 2009·10 cites·18 claims
- 1785US7084120B2Prodrugs of DP IV-inhibitorsPROBIODRUG AG·Filed 2000·Granted Aug 1, 2006·25 cites·7 claims
- 1881US7592467B2Inhibitors of prolyl endopeptidasePROBIODRUG AG·Filed 2006·Granted Sep 22, 2009·7 cites·44 claims
- 1981US7132104B1Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disordersPROBIODRUG AG·Filed 2001·Granted Nov 7, 2006·12 cites·3 claims
- 2077US7655684B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2008·Granted Feb 2, 2010·2 cites·18 claims
- 2176US7368421B2Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosisPROBIODRUG AG·Filed 2002·Granted May 6, 2008·4 cites·13 claims
- 2274US9173885B2InhibitorsPROBIODRUG AG·Filed 2013·Granted Nov 3, 2015·2 cites·32 claims
- 2374US7667044B2Compounds for the treatment of neurological disordersPROBIODRUG AG·Filed 2005·Granted Feb 23, 2010·2 cites·45 claims
- 2472US7144856B2Inhibitors of dipeptidyl peptidase IPROBIODRUG AG·Filed 2004·Granted Dec 5, 2006·1 cites·20 claims
- 2572US6559314B2Method for the production of thiazolidinPROBIODRUG AG·Filed 2001·Granted May 6, 2003·5 cites·12 claims
- 2670US7803810B2InhibitorsPROBIODRUG AG·Filed 2008·Granted Sep 28, 2010·1 cites·19 claims
- 2769US2010028918A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2009·Application pending·0 cites
- 2867US11045533B2Humanized antibodiesPROBIODRUG AG·Filed 2020·Granted Jun 29, 2021·0 cites·18 claims
- 2966US9610368B2Radiolabelled glutaminyl cyclase (QC) inhibitors and uses of samePROBIODRUG AG·Filed 2014·Granted Apr 4, 2017·0 cites·17 claims
- 3060US2010159032A1Combinations useful for the treatment of neuronal disordersPROBIODRUG AG·Filed 2009·Application pending·0 cites
- 3159US2008249083A1Novel genes related to glutaminyl cyclasePROBIODRUG AG·Filed 2007·Application pending·0 cites
- 3257US9157918B2Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)PROBIODRUG AG·Filed 2013·Granted Oct 13, 2015·0 cites·7 claims
- 3357US7897633B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2007·Granted Mar 1, 2011·0 cites·23 claims
- 3457US2017097365A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2016·Application pending·0 cites
- 3554US9657089B2Diagnostic antibody assayPROBIODRUG AG·Filed 2014·Granted May 23, 2017·0 cites·20 claims
- 3654US8859250B2Crystal structure of glutaminyl cyclasePROBIODRUG AG·Filed 2013·Granted Oct 14, 2014·0 cites·13 claims
- 3754US7728146B2Enzyme inhibitorsPROBIODRUG AG·Filed 2007·Granted Jun 1, 2010·0 cites·65 claims
- 3853US2015247180A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2015·Application pending·0 cites
- 3953US2005171112A1Combinations useful for the treatment of neuronal disordersPROBIODRUG AG·Filed 2004·Application pending·0 cites
- 4051US7335645B2Effectors of dipeptidyl peptidase IV for topical usePROBIODRUG AG·Filed 2005·Granted Feb 26, 2008·0 cites·16 claims
- 4151US2010099721A1Novel compounds for the treatment of neurological disordersPROBIODRUG AG·Filed 2009·Application pending·0 cites
- 4248US9676843B2Uses of antibodies directed against amyloid-βPROBIODRUG AG·Filed 2015·Granted Jun 13, 2017·0 cites·26 claims
- 4348US2010273835A1Novel compoundsPROBIODRUG AG·Filed 2008·Application pending·0 cites
- 4446US2015361167A1Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe)PROBIODRUG AG·Filed 2015·Application pending·0 cites
- 4546US2005137142A1Combinations useful for the treatment of neuronal disordersPROBIODRUG AG·Filed 2004·Application pending·0 cites
- 4645US9512115B2InhibitorsPROBIODRUG AG·Filed 2014·Granted Dec 6, 2016·0 cites·22 claims
- 4745US2008200567A1In vivo screening models for treatment of alzheimer's disease and other qpct-related disordersPROBIODRUG AG·Filed 2008·Application pending·0 cites
- 4843US9277737B2Mouse models carrying a knock-out mutation of the QPCTL-genePROBIODRUG AG·Filed 2013·Granted Mar 8, 2016·0 cites·19 claims
- 4942US2010234397A1Enzyme inhibitorsPROBIODRUG AG·Filed 2010·Application pending·0 cites
- 5041US7279550B2Irreversible cysteine protease inhibitors of legumainPROBIODRUG AG·Filed 2002·Granted Oct 9, 2007·0 cites·7 claims
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PROBIODRUG AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →